The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the primary staging of rectal cancer

World Journal of Surgical Oncology

Volumn 12, Issue 1, 2014, Pages

  Ozis, Salih E ^a   Soydal, Cigdem ^b   Akyol, Cihangir ^b   Can, Nalan ^c   Kucuk, Ozlem N ^b   Yagci, Cemil ^b   Erkek, Ayhan B ^b   Kuzu, Mehmet A ^b  

^a UFUK UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c Medicana Hospital   (Turkey)

Author keywords

18F flourodeoxyglucose (FDG) positron emission tomography (PET) computed tomography; Primary staging; Rectal cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISTANT METASTASIS; ENDOSCOPIC BIOPSY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PELVIS LYMPH NODE; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PROSPECTIVE STUDY; RECTUM CARCINOMA; VERY ELDERLY; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; METHODOLOGY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROGNOSIS; RADIOGRAPHY; RECTUM TUMOR; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84893379314     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-12-26     Document Type: Article

References (28)

1. Longo WE, Johnson FE. The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg Clin North Am 2002, 82(5):1091-1108. 10.1016/S0039-6109(02)00050-6, 12507211.
2. Gray R, Hills R, Stowe R, Clarke M, Peto R, Buyse M, Piedbois P, Glimelius B, Kerr D, Kodaira S, Metzger U, Nakazato H, Northover J, Rockette H, Wieand S, Wolmark N, Colorectal Cancer Collaborative Group Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001, 358(9290):1291-1304. Colorectal Cancer Collaborative Group.
3. Church JM, Gibbs P, Chao MW, Tjandra JJ. Optimizing the outcome for patients with rectal cancer. Dis Colon Rectum 2003, 46(3):389-402. 10.1007/s10350-004-6561-x, 12626917.
4. Chua TC, Chong CH, Liauw W, Morris DL. Approach to rectal cancer surgery. Int J Surg Oncol 2012, 2012:247107. 3389703, 22792451.
5. Tagliabue L. The emerging role of FDG PET/CT in rectal cancer management: is it time to use the technique for early prognostication?. Eur J Nucl Med Mol Imaging 2013, 40(5):652-656. 10.1007/s00259-013-2367-1, 23436074.
6. Kwak JY, Kim JS, Kim HJ, Ha HK, Yu CS, Kim JC. Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer. World J Surg 2012, 36(8):1898-1905. 10.1007/s00268-012-1575-3, 22526032.
7. Ozkan E, Soydal C, Araz M, Aras G. Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study. Nucl Med Commun 2012, 33(9):990-994. 10.1097/MNM.0b013e32835632ad, 22842225.
8. Ozkan E, Soydal C, Araz M, Kir KM, Ibis E. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels. Nucl Med Commun 2012, 33(4):395-402. 10.1097/MNM.0b013e32834f7dbe, 22367859.
9. Ivanoc O, Ivanov D, Mihailovic J, Erak M, Ivanov I, Basaric B. Importance of positron emission tomography-computed tomography (PET-CT) examination in rectal cancer staging-initial experience. Med Glas 2013, 10(2):303-308.
10. Cipe G, Ergul N, Hasbahceci M, Firat D, Bozkurt S, Memmi N, Karatepe O, Muslumanoglu M. Routine use of positron -emission tomography/computed tomography for staging of primary colorectal cancer: does it affect clinical management?. World J Surg Oncol 2013, 11:49. 10.1186/1477-7819-11-49, 3599376, 23445625.
11. Galandiuk S, Chaturvedi K, Topor B. Rectal cancer: a compartmental disease. The Mesorectum and Mesorectal Lymph Nodes. Rectal Cancer Treatment 2005, 21-29. Berlin: Springer, Büchler MW, Heald RJ, Ulrich B, Weitz J.
12. Abdel-Nabi H, Doerr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, Spaulding MB. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998, 206(3):755-760.
13. Mah K, Caldwell CB, Ung YC, Danjoux CE, Balogh JM, Ganguli SN, Ehrlich LE, Tirona R. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly-defined non-small-cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 2002, 52(2):339-350. 10.1016/S0360-3016(01)01824-7, 11872279.
14. Miller TR, Grigsby PW. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys 2002, 53(2):353-359. 10.1016/S0360-3016(02)02705-0, 12023139.
15. Ciernik IF, Dizendorf E, Baumert BG, Reiner B, Burger C, Davis JB, Lütolf UM, Steinert HC, Von Schulthess GK. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 2003, 57(3):853-863. 10.1016/S0360-3016(03)00346-8, 14529793.
16. Bradley J, Thorstad WL, Mutic S, Miller TR, Dehdashti F, Siegel BA, Bosch W, Bertrand RJ. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004, 59(1):78-86. 10.1016/j.ijrobp.2003.10.044, 15093902.
17. Gregoire V, Haustermans K, Geets X, Roels S, Lonneux M. PET-based treatment planning in radiotherapy: a new standard?. J Nucl Med 2007, 48(1):68S-77S.
18. Bassi MC, Turri L, Sacchetti G, Loi G, Cannillo B, La Mattina P, Brambilla M, Inglese E, Krengli M. FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys 2008, 70(5):1423-1426. 10.1016/j.ijrobp.2007.08.043, 17931795.
19. Davey K, Heriot AG, Mackay J, Drummond E, Hogg A, Ngan S, Milner AD, Hicks RJ. The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer. Dis Colon Rectum 2008, 51(7):997-1003. 10.1007/s10350-008-9244-1, 18461399.
20. Takeuchi O, Saito N, Koda K, Sarashina H, Nakajima N. Clinical assessment of positron emission tomography for the diagnosis of local recurrence in colorectal cancer. Br J Surg 1999, 86(7):932-937. 10.1046/j.1365-2168.1999.01178.x, 10417568.
21. Meta J, Seltzer M, Schiepers C, Silverman DH, Ariannejad M, Gambhir SS, Phelps ME, Valk P, Czernin J. Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective. J Nucl Med 2001, 42(4):586-590.
22. Kalff V, Hicks RJ, Ware RE, Hogg A, Binns D, McKenzie AF. The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med 2002, 43(4):492-499.
23. Denecke T, Rau B, Hoffmann KT, Hildebrandt B, Ruf J, Gutberlet M, Hünerbein M, Felix R, Wust P, Amthauer H. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?. Eur Radiol 2005, 15(8):1658-1666. 10.1007/s00330-005-2658-4, 15806369.
24. Heriot AG, Hicks RJ, Drummond EG, Keck J, Mackay J, Chen F, Kalff V. Does positron emission tomography change management in primary rectal cancer? A prospective assessment. Dis Colon Rectum 2004, 47(4):451-458. 10.1007/s10350-003-0089-3, 14978612.
25. Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, Gava M, Fanti S, Mariani G, Muzzio PC, Rubello D. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 2007, 34(10):1583-1593. 10.1007/s00259-007-0426-1, 17503039.
26. Even-Sapir E, Parag Y, Lerman H, Gutman M, Levine C, Rabau M, Figer A, Metser U. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 2004, 232(3):815-822. 10.1148/radiol.2323031065, 15273334.
27. Gearhart SL, Frassica D, Rosen R, Choti M, Schulick R, Wahl R. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Surg Oncol 2006, 13(3):397-404. 10.1245/ASO.2006.04.042, 16485158.
28. Eglinton T, Luck A, Bartholomeusz D, Varghese R, Lawrence M. Positron-emission tomography/computed tomography (PET/CT) in the initial staging of primary rectal cancer. Colorectal Dis 2010, 12(7):667-673.